Mary Porteous

20.9k total citations · 3 hit papers
101 papers, 7.4k citations indexed

About

Mary Porteous is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Mary Porteous has authored 101 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 22 papers in Molecular Biology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Mary Porteous's work include BRCA gene mutations in cancer (18 papers), Genetic factors in colorectal cancer (18 papers) and Colorectal Cancer Screening and Detection (10 papers). Mary Porteous is often cited by papers focused on BRCA gene mutations in cancer (18 papers), Genetic factors in colorectal cancer (18 papers) and Colorectal Cancer Screening and Detection (10 papers). Mary Porteous collaborates with scholars based in United Kingdom, United States and Netherlands. Mary Porteous's co-authors include Alan E. Guttmacher, Malcolm G. Dunlop, Douglas A. Marchuk, Susan M. Farrington, Harry Campbell, Nicholas J. Bradshaw, Albert Tenesa, Carol J. Gallione, Charles E. Jackson and Rebecca A. Barnetson and has published in prestigious journals such as New England Journal of Medicine, Cell and Nature Genetics.

In The Last Decade

Mary Porteous

98 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

1994 1.1k citations Kimberly A. McAllister, David W. Johnson et al. profile →
Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2

1996 846 citations David W. Johnson, Jonathan Berg et al. profile →
Integrated care pathways

1998 671 citations Mary Porteous et al. profile →

Peers

Countries citing papers authored by Mary Porteous

Since Specialization

Citations

This map shows the geographic impact of Mary Porteous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Porteous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Porteous more than expected).

Fields of papers citing papers by Mary Porteous

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Porteous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Porteous. The network helps show where Mary Porteous may publish in the future.

Co-authorship network of co-authors of Mary Porteous

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Porteous. A scholar is included among the top collaborators of Mary Porteous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Porteous. Mary Porteous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating the effectiveness of commercially available mouthwash on SARS-CoV-2 in vivo using viable virus titre as the primary outcome. A randomised controlled trial 2024 ·Access Microbiology ·David Seymour, (unknown), Mary Porteous, Damian Mawer, (unknown), Alex Mitchell, Catherine Hewitt, (unknown), Katherine Davies, David J. Jackson, M.J. Hannah, (unknown), Ulrike Arnold, Ryan T. Strachan, Marian J. Killip, Peter J. Nixon	0
2	Mainstreaming BRCA1 and BRCA2 testing: an interview study of healthcare professionals' views 2019 ·European Journal of Human Genetics ·(unknown), D. Stirling, (unknown), (unknown), (unknown), Mary Porteous, Nina Hallowell	1
3	15.33 Phenotype-genotype characterisation of ‘long survivors’ with motor neurone disease in Scotland 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·Danielle Leighton, Judith Newton, David Parry, Shuna Colville, Robert Swingler, Mary Porteous, Timothy J. Aitman, George Gorrie, Siddharthan Chandran, Suvankar Pal	0
4	Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·Caroline McHutchison, Danielle Leighton, Andrew M. McIntosh, Elaine Cleary, Jon Warner, Mary Porteous, Siddharthan Chandran, Suvankar Pal, Sharon Abrahams	17
5	Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions 2016 ·Molecular and Cellular Probes ·Elaine Cleary, Suvankar Pal, (unknown), David Moore, Robert Swingler, George Gorrie, Laura Stephenson, Shuna Colville, Siddharthan Chandran, Mary Porteous, Jon Warner	33
6	A qualitative study of patients’ perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH) 2016 ·Journal of Community Genetics ·Nina Hallowell, Nicholas Jenkins, M. Joanne Douglas, Simon W. Walker, (unknown), Mary Porteous, Julia Lawton	11
7	Diet, Environmental Factors, and Lifestyle Underlie the High Prevalence of Vitamin D Deficiency in Healthy Adults in Scotland, and Supplementation Reduces the Proportion That Are Severely Deficient 2011 ·Journal of Nutrition ·Lina Zgaga, Evropi Τheodoratou, Susan M. Farrington, Felix Agakov, Albert Tenesa, Marion Walker, Susan Knox, A. Michael Wallace, Roseanne Cetnarskyj, Geraldine McNeill, J. Kyle, Mary Porteous, (unknown), Harry Campbell	74
8	How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? A UK-based qualitative interview study 2011 ·Patient Education and Counseling ·Nicholas Jenkins, Julia Lawton, M. Joanne Douglas, Simon W. Walker, (unknown), Mary Porteous, Nina Hallowell	18
9	Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding 2008 ·International Journal of Cancer ·Evropi Τheodoratou, Susan M. Farrington, Albert Tenesa, Geraldine McNeill, Roseanne Cetnarskyj, Rebecca A. Barnetson, Mary Porteous, Malcolm G. Dunlop, Harry Campbell	50
10	Reply to Webb et al. 2006 ·The American Journal of Human Genetics ·Susan M. Farrington, Albert Tenesa, Rebecca A. Barnetson, (unknown), James Prendergast, Mary Porteous, Harry Campbell, Malcolm G. Dunlop	1
11	Germline Susceptibility to Colorectal Cancer Due to Base-Excision Repair Gene Defects 2005 ·The American Journal of Human Genetics ·Susan M. Farrington, Albert Tenesa, Rebecca A. Barnetson, (unknown), James Prendergast, Mary Porteous, Harry Campbell, Malcolm G. Dunlop	208
12	Referrals of patients to colorectal cancer genetics services in south-east Scotland 2005 ·Familial Cancer ·Susan Holloway, Mary Porteous, Roseanne Cetnarskyj, Robert Rush, (unknown), Dermot Gorman, Harry Campbell	8
13	Spinocerebellar ataxia type 8 in Scotland 2004 ·Journal of Neurology Neurosurgery & Psychiatry ·Adam Zeman, Jon Stone, Mary Porteous, Edith Burns, L Barron, Jon Warner	1
14	The development of a psychoeducational intervention for women living with an increased risk of breast cancer 2003 ·Patient Education and Counseling ·(unknown), Sixto García‐Miñáur, Mary Porteous, Joyce Campbell, Elaine Anderson, Maggie Watson, Ann Cull	6
15	Further evidence of genetic heterogeneity in hereditary hydronephrosis 1996 ·Clinical Genetics ·Duncan P. McHale, Mary Porteous, (unknown), (unknown)	4
16	A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. 1995 ·Genome Research ·David W. Johnson, Jonathan Berg, Carol J. Gallione, Kimberly A. McAllister, Jon Warner, E.A. Helmbold, Dorene S. Markel, Charles E. Jackson, Mary Porteous, Douglas A. Marchuk	124
17	A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly 1994 ·Molecular and Cellular Probes ·Caroline Hayward, Mary Porteous, D. J. H. Brock	32
18	VACTERL with hydrocephalus: One end of the Fanconi anemia spectrum of anomalies? 1992 ·American Journal of Medical Genetics ·Mary Porteous, I Cross, John Burn	43
19	Association of less common cystic fibrosis mutations with a mild phenotype. 1991 ·Journal of Medical Genetics ·Ann Curtis, Roger Nelson, Mary Porteous, John Burn, Siladitya Bhattacharya	17
20	Abstracts of the joint meeting of the Clinical Genetics Society and the Clinical Molecular Genetics Society held on 19 and 20 April 1990 at University of Newcastle upon Tyne Medical School 1990 ·Journal of Medical Genetics ·Mary Porteous, John Burn, (unknown), C. Geoffrey Woods, Sarah Bundey, A. Malcolm R. Taylor	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact